alexa Evaluation Of Adverse Drug Reactions In A South Indian Tertiary Care Teaching Hospital: A Prospective Observational Study | 23092
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Mallesh M and K Purushothama Reddy
Accepted Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.015
Abstract
Adverse Drug Reactions (ADRs) are a great cause of concern to the health care professionals. However ADR reporting and monitoring is yet to be catch up in India. A prospective observational study was conducted between June 2012 and May 2014 to record and analyze ADRs among all patients admitted to the medical wards at Rajiv Gandhi Institute of Medical Sciences (RIMS) an 800 bedded tertiary care teaching hospital. A total of 21829 (Inpatient) patients were admitted & 69453 (Outpatient) were consulted during the study period including all the departments in the RIMS. Prescription of Antibiotics (37%) were high followed by Anti-ulceratives (16%), Anti-tubercular drugs (14. 7%) and least prescribed were Anti-Parkinson?s drugs (1. 1%). A total of 21743 ADRs were identified, the most of the ADRs were mild (61. 9%), severe were least (17. 9%) and the moderate were between them (20. 2%). Highest incidence is of GI effects (27. 9%) followed by thrombophlebitis (19. 8%) and the lowest is of tinnitus (1. 61%). ADRs were identified by clinical pharmacists (79%), physicians (9%), nurses (5%) patients (4%) and patient representatives (3%) and all the ADRs were documented by clinical pharmacist in Drug Information Center (DIC). There is a need for vigilant ADR monitoring to be done by all health care professionals to prevent morbidity and mortality from ADRs.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version